Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110003089A details high-yield carbazole synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN119930443A details a visible light photocatalytic method for trifluoromethylation. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel salt-based purification method for Rebamipide achieving >99.8% purity. Reduces impurities significantly using simple solvents. Ideal for pharmaceutical manufacturing.
Patent CN118666669A reveals efficient asymmetric synthesis for sitafloxacin intermediates. Achieve high purity and scalable production with reduced operational complexity.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Patent CN102627684A reveals chromium-free oxidation. Enhances supply chain reliability and reduces environmental waste for pharmaceutical intermediates.
Patent CN108129357B details a novel one-pot method for producing high-purity anamorelin intermediates, offering significant safety and cost advantages for pharmaceutical supply chains.
Novel taurine-catalyzed synthesis offers green efficiency. Reliable supply chain for pharmaceutical intermediates with reduced environmental impact and cost.
Patent CN115369430A reveals a green electrochemical route for C-3 aminomethylation. Achieves high yields without external oxidants, offering cost-effective manufacturing for pharma intermediates.
Patent CN106146316A reveals high-selectivity boron catalysis for 1,2-diaryl ethylenediamines. Enables cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Discover advanced benzomorpholone derivatives for oncology. Our patented synthesis offers cost-effective, scalable manufacturing for high-purity BET inhibitor intermediates.
Patent CN113735770B details a novel Rh-catalyzed route to 1-aminoisoquinolines using vinylene carbonate, offering safer reagents and improved atom economy for industrial API manufacturing.
Patent CN109942514A reveals efficient Ir-catalyzed route for Atazanavir intermediate. Enables cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN114133323B reveals a safe TMSCN-based route for morphine precursors, offering significant yield improvements and cost reduction in API manufacturing.
Patent CN113045501B details a novel low-cost synthesis for 7-methyl-2-n-propyl-3H-benzimidazole-5-aldehyde, offering significant supply chain and purity advantages.
Advanced preparation method for Oxitinib Mesylate intermediates via anhydrous catalysis. Delivers high purity, reduced genotoxic impurities, and scalable manufacturing for global supply chains.
Discover the industrial production method for nitrogen-containing heterocyclic compounds with excellent FLT3 inhibitory activity. Optimized for high purity and scalable manufacturing.
Novel patent CN120943777A details high-yield carteolol hydrochloride synthesis. Eliminates chromatography, ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers seeking reliable partners.
Novel double oxidation method for chiral tetrahydroquinoline. High enantioselectivity and substrate universality for pharmaceutical manufacturing.
Patent CN105566181B offers a green route for 4-methylsulfonyltoluene. Enhances supply chain reliability and reduces waste for pharmaceutical intermediate manufacturing.